News Release Dated November 14, 2023
Company: Japan System Techniques Co., Ltd.
Representative: Takeaki Hirabayashi, President and CEO
Stock code: 4323, Tokyo Stock Exchange, Prime Market
Contact: Taku Hirabayashi, Director and Officer
Tel: +81-6-4560-1000

Start of Joint Research to Estimate the Economic Benefits of New Drugs
Japan System Techniques Co., Ltd. (JAST) and Yasushi Hara, an Associate Professor at Kobe University,
have started a joint research program using JAST’s medical big data for the purpose of estimating theeconomic benefits of new drugs. The details are as per attached.
The earnings forecast announced on May 12, 2023 incorporates the effect of this matter on the results ofoperations for the fiscal year ending March 2024. An announcement will be made promptly if there is any
additional information that should be disclosed.

NEWS RELEASE

November 14, 2023
Japan System Techniques Co., Ltd.
Kobe University

Start of Joint Research to Estimate the Economic Benefits of New Drugs
Japan System Techniques Co., Ltd. (Head office: Osaka, Representative: Takeaki Hirabayashi, President and CEO; JAST)
and Yasushi Hara, an Associate Professor at Kobe University, have started a joint research program using JAST’s medical
big data for the purpose of estimating the economic benefits of new drugs.
■The Joint Research Program

The joint research program involves the analysis of data in order to determine how drugs with an even higher efficacy andmobile medical devices can improve the quality of life of patients. Combining health check-up data and health insurance
invoice data* makes it possible to observe the effects on individual patients of new medical innovations. In addition, patent
data and other information is utilized in order to measure the benefits of intellectual property.
■

Expected Benefits of the Joint Research Program

The use of invoice data and health check-up data for individual patients makes it possible to obtain the benefits ofrevolutionary pharmaceutical and other medical innovations at the micro level. Many types of drugs are now used in addition
to the conventional small-molecule drugs, such as antibody drugs and regenerative medicine. This program has the goal ofusing evidence to monitor these changes in drugs and playing a role in discussions for deciding the types of systems shouldbe established.
(Yasushi Hara, Associate Professor, Graduate School of Business Administration, Kobe University)■

The Future Co-Creation Laboratory of JASTThe Future Co-Creation Laboratory of JAST is a medical big data business with the mission of using the digital transformationof health care backed by medical big data (invoice data, health check-up data and other data) to solve issues at healthcare
facilities and insurance companies and organizations. This laboratory will continue to analyze information obtained fromresearch activities in order to raise the value of JAST’s data and create more ways to solve the issues of customers.
Operations of The Future Co-Creation Laboratory also contribute to accomplishing Sustainable Development Goals number
three, good health and well-being, and nine, industry, innovation and infrastructure. These activities include the use of medical
big data to enable people to stay healthy and the use of alliances with the academic sector for joint research and thedevelopment of products.

1

NEWS RELEASE* Health insurance invoice data
When an individual receives a medical treatment covered by insurance, the healthcare institution sends an invoice listing theprocedures and amounts due to the insurance company or organization. For medical and dental care, an invoice listing theprocedures and amounts due is sent. For pharmacies, an invoice listing the drugs supplied and amounts due is sent. For nurses
visiting individuals at home, an invoice listing home nursing care services and amounts due is sent. One invoice for eachpatient and individual healthcare institution is prepared every month. Invoices contain information about the reasons thatindividuals received medical care, the cost of the care and other items. JAST converts this information into a database forsubsequent utilization.
Inquiries
The Future Co-Creation Laboratory, Japan System Techniques Co., Ltd.
Contact for more information (redirected to an external website): https://www.jastlab.jast.jp/contact/
Website of The Future Co-Creation Laboratory: https://www.jastlab.jast.jp/
Laboratory of Yasushi Hara, Graduate School of Business Administration, Kobe University
Tel: +81-78-803-7260 (ext. 6926) E-mail：yasushi.hara@people.kobe-u.ac.jp2